Hält derzeit Positionen bei La Jolla Pharmaceutical Co, Odonate Therapeutics Inc and Heron Therapeutics Inc
Position | Company | Period |
---|---|---|
Chairman of the Board | La Jolla Pharmaceutical Co | 1. August 2014 - |
Chairman of the Board, Chief Executive Officer | Odonate Therapeutics Inc | 1. Januar 2013 - |
Independent Chairman of the Board | Heron Therapeutics Inc | 30. Juli 2012 - |
Independent Director | Heron Therapeutics Inc | 8. Februar 2009 - 30. Juli 2012 |
Independent Director | Ardea Biosciences Inc | 1. Mai 2003 - 19. Juni 2012 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-12-18 | 2023-12-18 |
Rain Therapeutics Inc
(RAIN)
|
V Verkauf |
40.132
-1.0%
1,2148.560 USD |
40.132 -1.0% | 1,21 | 48.560 USD | |
2023-12-18 | 2023-12-15 |
Rain Therapeutics Inc
(RAIN)
|
V Verkauf |
109.435
-2.7%
1,20131.322 USD |
109.435 -2.7% | 1,20 | 131.322 USD | |
2023-12-18 | 2023-12-14 |
Rain Therapeutics Inc
(RAIN)
|
V Verkauf |
24.406
-0.6%
1,2129.531 USD |
24.406 -0.6% | 1,21 | 29.531 USD | |
2023-10-13 | 2023-10-13 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
84.145
+2.1%
0,9983.304 USD |
84.145 +2.1% | 0,99 | 83.304 USD | |
2023-10-13 | 2023-10-13 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
47.486
+1.2%
0,9947.011 USD |
47.486 +1.2% | 0,99 | 47.011 USD | |
2023-10-13 | 2023-10-12 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
52.514
+1.4%
0,9851.464 USD |
52.514 +1.4% | 0,98 | 51.464 USD | |
2023-10-13 | 2023-10-12 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
25.188
+0.7%
0,9824.684 USD |
25.188 +0.7% | 0,98 | 24.684 USD | |
2023-10-13 | 2023-10-11 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
74.812
+2.0%
0,9772.568 USD |
74.812 +2.0% | 0,97 | 72.568 USD | |
2023-06-01 | 2023-06-01 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
240.341
+6.9%
1,12269.182 USD |
240.341 +6.9% | 1,12 | 269.182 USD | |
2023-06-01 | 2023-06-01 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
92.984
+2.7%
1,09101.353 USD |
92.984 +2.7% | 1,09 | 101.353 USD | |
2023-06-01 | 2023-05-30 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
2.016
+0.1%
1,082.177 USD |
2.016 +0.1% | 1,08 | 2.177 USD | |
2023-06-01 | 2023-05-30 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
32.890
+1.0%
1,0634.863 USD |
32.890 +1.0% | 1,06 | 34.863 USD | |
2023-06-01 | 2023-05-30 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
200.000
+6.7%
1,00200.000 USD |
200.000 +6.7% | 1,00 | 200.000 USD | |
2023-06-01 | 2023-05-30 |
Rain Therapeutics Inc
(RAIN)
|
K Kauf |
347.932
+13.1%
1,05365.329 USD |
347.932 +13.1% | 1,05 | 365.329 USD | |
2023-05-30 | 2023-05-25 |
TCR2 Therapeutics Inc
(TCRR)
|
K Kauf |
50.000
+1.2%
1,7286.000 USD |
50.000 +1.2% | 1,72 | 86.000 USD | |
2023-05-15 | 2023-05-12 |
TCR2 Therapeutics Inc
(TCRR)
|
K Kauf |
6.183
+0.1%
1,9512.057 USD |
6.183 +0.1% | 1,95 | 12.057 USD | |
2023-05-15 | 2023-05-11 |
TCR2 Therapeutics Inc
(TCRR)
|
K Kauf |
38.765
+0.9%
1,9575.592 USD |
38.765 +0.9% | 1,95 | 75.592 USD | |
2023-05-10 | 2023-05-10 |
TCR2 Therapeutics Inc
(TCRR)
|
K Kauf |
6.774
+0.2%
1,9513.209 USD |
6.774 +0.2% | 1,95 | 13.209 USD | |
2023-05-10 | 2023-05-09 |
TCR2 Therapeutics Inc
(TCRR)
|
K Kauf |
20.141
+0.5%
1,9539.275 USD |
20.141 +0.5% | 1,95 | 39.275 USD | |
2023-05-10 | 2023-05-08 |
TCR2 Therapeutics Inc
(TCRR)
|
K Kauf |
57.073
+1.4%
1,95111.292 USD |
57.073 +1.4% | 1,95 | 111.292 USD | |
2023-05-05 | 2023-05-05 |
TCR2 Therapeutics Inc
(TCRR)
|
K Kauf |
71.064
+1.7%
1,94137.864 USD |
71.064 +1.7% | 1,94 | 137.864 USD | |
2023-05-05 | 2023-05-05 |
TCR2 Therapeutics Inc
(TCRR)
|
K Kauf |
95.759
+2.4%
1,90181.942 USD |
95.759 +2.4% | 1,90 | 181.942 USD | |
2023-05-05 | 2023-05-04 |
TCR2 Therapeutics Inc
(TCRR)
|
K Kauf |
104.241
+2.6%
1,86193.888 USD |
104.241 +2.6% | 1,86 | 193.888 USD | |
2023-05-05 | 2023-05-03 |
TCR2 Therapeutics Inc
(TCRR)
|
K Kauf |
18.513
+0.5%
1,8534.249 USD |
18.513 +0.5% | 1,85 | 34.249 USD | |
2023-03-14 | 2023-03-14 |
Jounce Therapeutics Inc
(JNCE)
|
K Kauf |
20.286
+0.4%
1,0220.651 USD |
20.286 +0.4% | 1,02 | 20.651 USD | |
2023-03-14 | 2023-03-13 |
Jounce Therapeutics Inc
(JNCE)
|
K Kauf |
65.701
+1.3%
0,9965.307 USD |
65.701 +1.3% | 0,99 | 65.307 USD | |
2021-12-01 | 2021-12-01 |
La Jolla Pharmaceutical Co
(LJPC)
|
V Verkauf |
41.290
-0.4%
3,66151.303 USD |
41.290 -0.4% | 3,66 | 151.303 USD | |
2021-12-01 | 2021-12-01 |
La Jolla Pharmaceutical Co
(LJPC)
|
V Verkauf |
136.255
-1.4%
3,76512.128 USD |
136.255 -1.4% | 3,76 | 512.128 USD | |
2021-12-01 | 2021-11-30 |
La Jolla Pharmaceutical Co
(LJPC)
|
V Verkauf |
63.745
-0.6%
3,95251.544 USD |
63.745 -0.6% | 3,95 | 251.544 USD | |
2021-12-01 | 2021-11-30 |
La Jolla Pharmaceutical Co
(LJPC)
|
V Verkauf |
6.597
-0.1%
3,9526.067 USD |
6.597 -0.1% | 3,95 | 26.067 USD | |
2021-12-01 | 2021-11-29 |
La Jolla Pharmaceutical Co
(LJPC)
|
V Verkauf |
193.403
-1.9%
4,10793.107 USD |
193.403 -1.9% | 4,10 | 793.107 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
160.000
-100.0%
9,601.536.560 USD |
160.000 -100.0% | 9,60 | 1.536.560 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
200.000
-55.6%
10,072.014.440 USD |
200.000 -55.6% | 10,07 | 2.014.440 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
50.889
-12.4%
10,43530.665 USD |
50.889 -12.4% | 10,43 | 530.665 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
149.111
-26.6%
11,191.668.433 USD |
149.111 -26.6% | 11,19 | 1.668.433 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
75.491
-11.9%
11,74886.430 USD |
75.491 -11.9% | 11,74 | 886.430 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
124.509
-16.4%
12,451.550.187 USD |
124.509 -16.4% | 12,45 | 1.550.187 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
161.336
-17.5%
13,522.181.521 USD |
161.336 -17.5% | 13,52 | 2.181.521 USD | |
2021-11-22 | 2021-11-22 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
38.664
-4.0%
6,55253.373 USD |
38.664 -4.0% | 6,55 | 253.373 USD | |
2021-11-22 | 2021-11-22 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
3.719
-0.4%
6,6624.779 USD |
3.719 -0.4% | 6,66 | 24.779 USD | |
2021-11-22 | 2021-11-22 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
196.281
-16.9%
7,111.395.185 USD |
196.281 -16.9% | 7,11 | 1.395.185 USD | |
2021-11-22 | 2021-11-22 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
16.667
-1.4%
7,36122.651 USD |
16.667 -1.4% | 7,36 | 122.651 USD | |
2021-11-22 | 2021-11-19 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
183.333
-13.5%
7,521.378.756 USD |
183.333 -13.5% | 7,52 | 1.378.756 USD | |
2021-11-22 | 2021-11-19 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
30.467
-2.2%
8,01244.111 USD |
30.467 -2.2% | 8,01 | 244.111 USD | |
2021-11-19 | 2021-11-19 |
Odonate Therapeutics Inc
(ODT)
|
V Verkauf |
365.289
-2.8%
1,92699.930 USD |
365.289 -2.8% | 1,92 | 699.930 USD | |
2021-11-22 | 2021-11-18 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
169.533
-10.9%
8,091.372.319 USD |
169.533 -10.9% | 8,09 | 1.372.319 USD | |
2021-11-22 | 2021-11-18 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
4.023
-0.3%
8,0032.190 USD |
4.023 -0.3% | 8,00 | 32.190 USD | |
2021-11-22 | 2021-11-18 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
152.764
-8.9%
8,321.271.516 USD |
152.764 -8.9% | 8,32 | 1.271.516 USD | |
2021-11-22 | 2021-11-18 |
Aptevo Therapeutics Inc
(APVO)
|
V Verkauf |
43.213
-2.5%
9,38405.532 USD |
43.213 -2.5% | 9,38 | 405.532 USD | |
2021-11-19 | 2021-11-18 |
Odonate Therapeutics Inc
(ODT)
|
V Verkauf |
381.842
-2.8%
1,89722.636 USD |
381.842 -2.8% | 1,89 | 722.636 USD | |
2021-11-19 | 2021-11-18 |
Odonate Therapeutics Inc
(ODT)
|
V Verkauf |
500.000
-3.6%
1,88940.600 USD |
500.000 -3.6% | 1,88 | 940.600 USD | |
2021-11-19 | 2021-11-18 |
Odonate Therapeutics Inc
(ODT)
|
V Verkauf |
212.423
-1.5%
1,97418.643 USD |
212.423 -1.5% | 1,97 | 418.643 USD | |
2021-11-19 | 2021-11-17 |
Odonate Therapeutics Inc
(ODT)
|
V Verkauf |
287.577
-2.0%
2,20632.238 USD |
287.577 -2.0% | 2,20 | 632.238 USD | |
2021-11-19 | 2021-11-17 |
Odonate Therapeutics Inc
(ODT)
|
V Verkauf |
500.000
-3.3%
2,021.008.050 USD |
500.000 -3.3% | 2,02 | 1.008.050 USD | |
2021-11-19 | 2021-11-17 |
Odonate Therapeutics Inc
(ODT)
|
V Verkauf |
31.151
-0.2%
1,9962.118 USD |
31.151 -0.2% | 1,99 | 62.118 USD | |
2021-11-19 | 2021-11-17 |
Odonate Therapeutics Inc
(ODT)
|
V Verkauf |
468.849
-3.0%
2,661.246.341 USD |
468.849 -3.0% | 2,66 | 1.246.341 USD | |
2021-05-26 | 2021-05-26 |
La Jolla Pharmaceutical Co
(LJPC)
|
K Kauf |
166.932
+1.7%
4,26710.763 USD |
166.932 +1.7% | 4,26 | 710.763 USD | |
2021-05-26 | 2021-05-25 |
La Jolla Pharmaceutical Co
(LJPC)
|
K Kauf |
31.782
+0.3%
3,83121.874 USD |
31.782 +0.3% | 3,83 | 121.874 USD | |
2021-05-26 | 2021-05-25 |
La Jolla Pharmaceutical Co
(LJPC)
|
K Kauf |
95.597
+1.0%
3,77360.860 USD |
95.597 +1.0% | 3,77 | 360.860 USD | |
2021-05-26 | 2021-05-24 |
La Jolla Pharmaceutical Co
(LJPC)
|
K Kauf |
104.403
+1.1%
3,68384.234 USD |
104.403 +1.1% | 3,68 | 384.234 USD | |
2020-12-23 | 2020-12-23 |
Odonate Therapeutics Inc
(ODT)
|
K Kauf |
75.784
+0.5%
15,711.190.415 USD |
75.784 +0.5% | 15,71 | 1.190.415 USD | |
2020-12-23 | 2020-12-23 |
Odonate Therapeutics Inc
(ODT)
|
K Kauf |
63.354
+0.4%
15,43977.438 USD |
63.354 +0.4% | 15,43 | 977.438 USD | |
2020-12-23 | 2020-12-22 |
Odonate Therapeutics Inc
(ODT)
|
K Kauf |
36.646
+0.2%
15,17555.821 USD |
36.646 +0.2% | 15,17 | 555.821 USD | |
2020-12-23 | 2020-12-22 |
Odonate Therapeutics Inc
(ODT)
|
K Kauf |
37.856
+0.2%
14,58551.766 USD |
37.856 +0.2% | 14,58 | 551.766 USD | |
2020-12-23 | 2020-12-21 |
Odonate Therapeutics Inc
(ODT)
|
K Kauf |
62.144
+0.4%
14,58905.767 USD |
62.144 +0.4% | 14,58 | 905.767 USD | |
2020-11-06 | 2020-11-06 |
Aptevo Therapeutics Inc
(APVO)
|
K Kauf |
2.650
+0.2%
23,8763.256 USD |
2.650 +0.2% | 23,87 | 63.256 USD | |
2020-11-06 | 2020-11-06 |
Aptevo Therapeutics Inc
(APVO)
|
K Kauf |
107.901
+6.5%
23,482.533.515 USD |
107.901 +6.5% | 23,48 | 2.533.515 USD | |
2020-11-06 | 2020-11-06 |
Aptevo Therapeutics Inc
(APVO)
|
K Kauf |
29.682
+1.8%
22,33662.799 USD |
29.682 +1.8% | 22,33 | 662.799 USD | |
2020-11-06 | 2020-11-06 |
Aptevo Therapeutics Inc
(APVO)
|
K Kauf |
34.044
+2.1%
20,63702.328 USD |
34.044 +2.1% | 20,63 | 702.328 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
K Kauf |
8.482
+0.5%
20,94177.613 USD |
8.482 +0.5% | 20,94 | 177.613 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
K Kauf |
137.241
+9.5%
20,782.851.868 USD |
137.241 +9.5% | 20,78 | 2.851.868 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
K Kauf |
171.626
+13.5%
23,794.082.983 USD |
171.626 +13.5% | 23,79 | 4.082.983 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
K Kauf |
71.241
+6.0%
15,321.091.412 USD |
71.241 +6.0% | 15,32 | 1.091.412 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
K Kauf |
77.133
+6.9%
14,221.096.831 USD |
77.133 +6.9% | 14,22 | 1.096.831 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
K Kauf |
160.000
+16.7%
15,312.449.600 USD |
160.000 +16.7% | 15,31 | 2.449.600 USD |